Search
for
Sort by
Research 121–150 of 1000+
- Is dehydroepiandrosterone a hormone?
- In vivo and in vitro effect of novel 4,16-pregnadiene-6,20-dione derivatives, as 5α-reductase inhibitors
- FCE 28260, a new 5α-reductase inhibitor: In vitro and in vivo effects
- Is the metabolism of testosterone to 5α-dihydrotestosterone required for androgen action in the skin?
- Effect of Citrullus colocynthis Schard on Testosterone-Induced Benign Prostatic Hyperplasia
- Crystal Structure and Synthesis of 17.ALPHA.-Acetoxy-6,7-epoxypregn-4-ene-3,20-dione
- Serenoa repens: A Phytochemical and Pharmacological Review
- EP1446 - ECE_2942 - Finasteride for treatment of androgenic male alopecia since puberty: case report
- Focus sulla finasteride: efficacia, meccanismi e raccomandazioni per l'uso clinico
- Proscar and Propecia—A Therapeutic Perspective
- Editorial: Androgen-dependent diseases and their treatment
- Use of Antiandrogens as Therapeutic Agents in COVID-19 Patients
- Triple Hormonal Blockade (ADT3): A Patient’s Perspective
- Design of Liposome Formulations for CRISPR/Cas9 Enzyme Immobilization: Evaluation of 5-Alpha-Reductase Enzyme Knockout for Androgenic Disorders
- Regulation of masculinization: androgen signalling for external genitalia development
- Post-Finasteride Syndrome: An Underestimated Phenomenon
- HPLC Profiling and Insilco studies of Chochurus olitoris (Jute) Leave Fractions against Steroid 5α-Reductase 2 (SRD5α2)
- Pharmacological Profile of 9,11-Dehydrocortexolone 17α-Butyrate (CB-03-04), a New Androgen Antagonist with Antigonadotropic Activity
- Men??s Health
- The relevance of using 5α-reductase inhibitors in the conservative management of benign prostatic hyperplasia: A review
- Health Issues Unique to the Aging Man
- Clinics in diagnostic imaging (221)
- ChemInform Abstract: Rα‐Reductase Inhibitors‐ — The Finasteride Story
- Androgen Receptor Antagonists (Antiandrogens) Structure-Activity Relationships
- Maximum Efficacy of Finasteride Is Obtained within 6 Months and Maintained over 6 Years
- 5α‐Reductase inhibitors and prostatic disease
- New ester derivatives of dehydroepiandrosterone as 5α-reductase inhibitors
- Chapter 23. Therapeutic Control of Androgen Action
- 5-alpha reductase inhibitors: New evidences on benefits and harms beyond benign prostatic hyperplasia
- Treatment options for alopecia: an update, looking to the future